Pfizer has disclosed a $491 million charge for a Rapamune marketing settlement, fiercepharma.com reports, citing Dow Jones. The company made a deal with the US Justice Department to resolve the long-standing probe, which Pfizer inherited when it bought Wyeth in 2009....
Recent News: Whistleblower
Omeros Settles Wrongful Termination Suit With Former CFO for $3.9M
Omeros, the Seattle-based drug developer, has ended a long-running dispute with former chief financial officer Richard Klein by agreeing to pay him $3.94 million to settle a wrongful termination case he brought against the company three years ago. Omeros (NASDAQ:...
Orthofix Subsidiary, Blackstone Medical, Pays U.S. $30 Million to Settle False Claims Act Allegation
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Friday, November 2, 2012 Orthofix Subsidiary, Blackstone Medical, Pays U.S. $30 Million to Settle False Claims Act Allegations Allegedly Paid Kickbacks to Doctors to Induce Use of Company’s...
United States Sues Virginia-based Contractor for False Claims Under Contract for Security in Iraq
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Wednesday, October 31, 2012 United States Sues Virginia-based Contractor for False Claims UnderContract for Security in Iraq - Allegedly Billed US for Security Guards Who Did Not Meet Contract...
Texas secures $19.9M Novartis agreement over Medicaid fraud allegations
Austin Business Journal by Sarah Drake, Web Editor Date: Tuesday, October 30, 2012 The Texas Attorney General’s office has come to a $19.9 million agreement with Swiss pharmaceutical drug company Novartis over the alleged deceptive marketing of a topical skin cream...
Boehringer Ingelheim to Pay $95 Million to Resolve False Claims Act Allegations
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, October 25, 2012 Government Alleges Company Improperly Marketed Three Drugs Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations...
HCA Settles with Department of Justice for $16.5M
Nashville-based HCA Holdings (NYSE:HCA) has agreed to pay the federal government $16.5 million to settle accusations that subsidiaries of the nation's largest hospital chain paid physicians for referrals. The case arose from a whistleblower lawsuit filed in 2008 in...
Medical Supply Company Agrees to Pay $1.8 Million to Settle Claims of Fraudulent Medicare Billing
Another medical supply company has been held accountable for improper Medicare billing. According to a press release from the U.S. Department of Justice: A Mississippi medical equipment and supply company will pay about $1.8 million to settle claims that it...
Tennessee-Based Home Health Care Provider & Related Entities Agree to Pay More Than $9 M to Resolve False Claims Act Lawsuit
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE August 10, 2012 James W. Carell, CareAll Management LLC (formerly known as Diversified Health Management Inc.), Care All Inc., the...
Hospice Care of Kansas and Texas-based Parent Company to Pay $6.1 Million to Resolve Allegations of False Claims
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, June 21, 2012 Hospice Care of Kansas and Texas-based Parent Company to Pay $6.1 Million to Resolve Allegations of False Claims Allegedly Submitted False Claims for Patients Who Did Not Have...
AmMed Direct to Pay $18 Million to Settle Allegations That It Submitted False Claims to Medicare and TennCare
Nashville, TN. April 13, 2012 – Michael Hamilton of Provost Umphrey Law Firm LLP and Patrick Barrett of Barrett Law Office, PLLC are pleased to announce that AmMed Direct, LLC, a provider of diabetic testing supplies and other durable medical equipment, has agreed to...